moatshark My

All holdings

Elevance Health

ELV

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
9
In their latest 13F (Q3 2026)
See who
Value held
$5.0bn
Combined value at quarter end
Last quarter
4 bought
4 sold or trimmed
Fund portfolios
6
Funds holding it
See which
Price at Q2 ’26 end
$386.73
+32.1% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

-4.0%Q3 ’24
-29.1%Q4 ’24
+17.9%Q1 ’25
-10.6%Q2 ’25
-16.9%Q3 ’25
+8.5%Q4 ’25
-16.5%Q1 ’26
+32.1%Q2 ’26
Q3 ’24: -4.0%; Q4 ’24: -29.1%; Q1 ’25: +17.9%; Q2 ’25: -10.6%; Q3 ’25: -16.9%; Q4 ’25: +8.5%; Q1 ’26: -16.5%; Q2 ’26: +32.1%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

7Q4 ’23
7Q1 ’24
7Q2 ’24
7Q3 ’24
8Q4 ’24
9Q1 ’25
9Q2 ’25
10Q3 ’25
10Q4 ’25
10Q1 ’26
9Q2 ’26
0Q3 ’26
Q4 ’23: 7; Q1 ’24: 7; Q2 ’24: 7; Q3 ’24: 7; Q4 ’24: 8; Q1 ’25: 9; Q2 ’25: 9; Q3 ’25: 10; Q4 ’25: 10; Q1 ’26: 10; Q2 ’26: 9; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Elevance Health.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Elevance Health
Baupost Group9.1%$493m$493mUnchanged6 qtrs
Brave Warrior Advisors8.2%$378m$378mTrimmed -13%28 qtrs
Ruane, Cunniff & Goldfarb (Sequoia)5.9%$379m$379mTrimmed -29%22 qtrs
First Eagle Investment Management2.7%$1.6bn$1.6bnAdded +1.4%47 qtrs
Harris Associates (Oakmark)2.5%$1.9bn$1.9bnAdded +2.7%7 qtrs
Vulcan Value Partners1.8%$60.3m$60.3mTrimmed -47%16 qtrs
Yacktman Asset Management1.6%$131m$131mAdded +1.7%47 qtrs
Tweedy, Browne0.2%$2.5m$2.5mAdded +34%4 qtrs
Dodge & Cox0.0%$503k$503kUnchanged47 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of Elevance Health
Bought or soldFiling
17 Jul 2026Boudreaux GailPresident and CEO▲ Bought2,045$368.25$753kForm 4
17 Jul 2026Peru Ramiro GDirector▲ Bought1,000$366.05$366kForm 4
17 Jul 2026Boudreaux GailPresident and CEO▲ Bought680$366.41$249kForm 4

About the company

Sector
Health care · Hospital & Medical Service Plans
Incorporated in
Indiana
Financial year ends
31 December
Shares outstanding
217m at 10 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$71bn2013
$79bn2015
$90bn2017
$104bn2019
$139bn2021
$171bn2023
$199bn2025
2013: $71bn; 2014: $74bn; 2015: $79bn; 2016: $85bn; 2017: $90bn; 2018: $92bn; 2019: $104bn; 2020: $122bn; 2021: $139bn; 2022: $157bn; 2023: $171bn; 2024: $177bn; 2025: $199bn
Elevance Health revenue and net income by year
YearRevenueNet income
2025$199bn$5.7bn
2024$177bn$6.0bn
2023$171bn$6.0bn
2022$157bn$5.9bn
2021$139bn$6.2bn
2020$122bn$4.6bn
2019$104bn$4.8bn
2018$92bn$3.8bn
2017$90bn$3.8bn
2016$85bn$2.5bn
2015$79bn$2.6bn
2014$74bn$2.6bn
2013$71bn$2.5bn

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

Sold out last quarter

In fund portfolios

US-registered funds run by these managers that hold Elevance Health, from their latest N-PORT filings.

Funds holding Elevance Health
Sequoia FundRuane, Cunniff & Goldfarb (Sequoia)4.1%$150m30 Jun 2026
Vulcan Value Partners FundVulcan Value Partners3.6%$8.3m31 Jul 2026
Oakmark Global Select FundHarris Associates (Oakmark)3.6%$29.4m30 Jun 2026
Oakmark Global FundHarris Associates (Oakmark)2.2%$24.2m30 Jun 2026
AMG Yacktman FundYacktman Asset Management1.5%$112m30 Jun 2026
First Eagle Global FundFirst Eagle Investment Management1.4%$1.1bn31 Jul 2026